# Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight

> **NCT07110766** · PHASE1 · NOT_YET_RECRUITING · sponsor: **MindRank AI Ltd** · enrollment: 24 (estimated)

## Conditions studied

- Obesity &Amp; Overweight

## Interventions

- **DRUG:** MDR-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07110766
- **Lead sponsor:** MindRank AI Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-09
- **Primary completion:** 2025-09-15
- **Final completion:** 2025-10-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07110766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07110766, "Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07110766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*